featured
Association of Rituximab With the Risk of Long-Term Cardiovascular and Metabolic Outcomes in Patients With Pemphigus
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Association of Rituximab With Risk of Long-term Cardiovascular and Metabolic Outcomes in Patients With Pemphigus
JAMA Dermatol 2022 Nov 30;[EPub Ahead of Print], K Kridin, N Mruwat, RJ LudwigFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.